We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ZLAB market cap is 2.52B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 69.23M | 65.83M | 87.15M | 100.5M | 102.27M |
| Operating Income | -83.57M | -123.01M | -70.31M | -76.06M | -67.85M |
| Net Income | -69.15M | -95.43M | -53.47M | -80.28M | -41.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.99M | 48.96M | 144.31M | 215.04M | 266.72M |
| Operating Income | -203.2M | -301.77M | -698.7M | -403.88M | -375.6M |
| Net Income | -195.07M | -268.91M | -704.47M | -443.29M | -334.62M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.04B | 1.04B | 988.44M | 987.37M | 985.35M |
| Total Liabilities | 162.72M | 240.18M | 226.27M | 283.19M | 317.68M |
| Total Equity | 880.98M | 796.12M | 762.17M | 704.18M | 667.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 355.15M | 1.3B | 1.61B | 1.22B | 1.04B |
| Total Liabilities | 60.49M | 128.29M | 230M | 174.55M | 240.18M |
| Total Equity | 294.66M | 1.17B | 1.38B | 1.05B | 796.12M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -183.26M | -198.18M | -90.11M | -132.28M | -159.1M |
| Investing | -25.23M | -10.78M | 3.29M | 2.45M | -27.44M |
| Financing | -6.83M | -6.43M | 47.55M | 69.87M | 112.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -191.01M | -216.07M | -549.23M | -367.64M | -198.18M |
| Investing | -14.89M | -554.83M | 249.96M | 420.02M | -10.78M |
| Financing | 219.3M | 1.13B | 820.2M | -1.73M | -6.43M |
| Market Cap | 2.52B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 99.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.42 (5.61%) |
| Company Name | Zai Lab Ltd |
| Address |
po box 311 george town 11205 |
| Website | https://www.zailaboratory.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
